Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Sonic Healthcare.
RELATED STOCKHEAD STORIES
Health & Biotech
Scott Power: The lowdown on Sonic’s $700m German excursion
Health & Biotech
Health Check: Booming Sonic seals a $700 million German acquisition
Health & Biotech
Scott Power: Global health markets wobble as Trump picks RFK Jr for top health role
News
Closing Bell: ASX hits all-time high as tech stocks lead broad rally
Health & Biotech
Health Check: Sonic Healthcare is cashed up and ready to boom as earnings improve
Health & Biotech
Bio Curious: IPO candidate Stormeur to fly the ASX flag for billion-dollar beauty clinic sector
Health & Biotech
Health Check: Experts deliver their verdict on the Healius imaging deal and it’s ‘yeah nah’
Health & Biotech
Alive and Kicking: Kidney diagnosis house Proteomics divorces its US partner
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise but are ‘lacking any momentum’
Health & Biotech
ScoPo’s Powerplays: ASX health stocks up in ‘fairly lacklustre week’
Health & Biotech
ScoPo’s Powerplays: ASX health stocks hit resistance in first week of FY25
Experts
CRITERION: Time to take stock of your potential EOFY discards
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall as Sonic cuts FY24 profit guidance
News
ASX Small Caps Lunch Wrap: Gold and silver deliver as Star falls and stocks fail to rock
Health & Biotech
ASX Health Stocks: Telix says TLX592 shows promise in prostate cancer battle
Experts
Blood is thicker this quarter: Morningstar’s pathological outliers. Part 1. Sonic Healthcare
Health & Biotech
